Polyfunctional IL-21 <sup>+</sup> IFNγ <sup>+</sup> T follicular helper cells contribute to checkpoint inhibitor diabetes mellitus and can be targeted by JAK inhibitor therapy
Nicole Huang(University of California, Los Angeles), Melissa G. Lechner(University of California, Los Angeles)
Cited by 1
Related Papers
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|416
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium
|Journal of Clinical Oncology|2023|69
Inhibition of the IL-17A axis Protects against Immune-related Adverse Events while Supporting Checkpoint Inhibitor Anti-tumor Efficacy
|bioRxiv (Cold Spring Harbor Laboratory)|2022|2
240 Distinct patterns of copy number aberrations in penile cancer
|European Urology Supplements|2016|1